The Latest Headlines at American Banking and Market News
Cyba (LON:CYBA) Stock Price Up 6.9%
Cyba Plc (LON:CYBA – Get Free Report)’s share price rose 6.9% during trading on Thursday . The stock traded as high as GBX 1.55 ($0.02) and last traded at GBX 1.55 ($0.02). Approximately 22,111,331 shares were traded during... More of this article »
Formidable Fortress ETF (NYSEARCA:KONG) Trading Down 0.3%
Formidable Fortress ETF (NYSEARCA:KONG – Get Free Report)’s share price dropped 0.3% on Thursday . The company traded as low as $26.38 and last traded at $26.38. Approximately 5,254 shares were traded during mid-day trading,... More of this article »
Diversified Energy (LON:DEC) Trading Down 0.3%
Diversified Energy Company PLC (LON:DEC – Get Free Report) shares dropped 0.3% during trading on Thursday . The company traded as low as GBX 1,088 ($13.54) and last traded at GBX 1,094 ($13.62). Approximately 162,817 shares were... More of this article »
UBS Group Increases Regeneron Pharmaceuticals (NASDAQ:REGN) Price Target to $1,099.00
Regeneron Pharmaceuticals (NASDAQ:REGN – Get Free Report) had its price objective increased by equities researchers at UBS Group from $1,090.00 to $1,099.00 in a report released on Wednesday, Benzinga reports. The firm presently... More of this article »
Amgen (NASDAQ:AMGN) PT Lowered to $284.00
Amgen (NASDAQ:AMGN – Get Free Report) had its price objective decreased by equities research analysts at UBS Group from $314.00 to $284.00 in a research note issued to investors on Wednesday, Benzinga reports. The brokerage... More of this article »
UBS Group Lowers MercadoLibre (NASDAQ:MELI) Price Target to $1,800.00
MercadoLibre (NASDAQ:MELI – Get Free Report) had its price target lowered by UBS Group from $1,900.00 to $1,800.00 in a research report issued to clients and investors on Wednesday, Benzinga reports. The brokerage currently... More of this article »
Vertex Pharmaceuticals (NASDAQ:VRTX) Price Target Cut to $466.00
Vertex Pharmaceuticals (NASDAQ:VRTX – Get Free Report) had its target price cut by stock analysts at UBS Group from $498.00 to $466.00 in a research report issued on Wednesday, Benzinga reports. The firm presently has a “buy”... More of this article »
Gilead Sciences (NASDAQ:GILD) PT Lowered to $75.00
Gilead Sciences (NASDAQ:GILD – Get Free Report) had its target price lowered by equities research analysts at UBS Group from $81.00 to $75.00 in a report released on Wednesday, Benzinga reports. The brokerage currently has a... More of this article »-logo-1200x675.png?v=20240125142140&w=240&h=220&zc=2){kind=logo}
Telefonaktiebolaget LM Ericsson (publ) (NASDAQ:ERIC) Price Target Cut to $5.58
Telefonaktiebolaget LM Ericsson (publ) (NASDAQ:ERIC – Get Free Report) had its price target dropped by stock analysts at JPMorgan Chase & Co. from $5.81 to $5.58 in a research report issued to clients and investors on Wednesday,... More of this article »
Federated Hermes (NYSE:FHI) PT Raised to $47.00 at JPMorgan Chase & Co.
Federated Hermes (NYSE:FHI – Get Free Report) had its price target hoisted by equities research analysts at JPMorgan Chase & Co. from $46.00 to $47.00 in a report issued on Wednesday, Benzinga reports. The brokerage presently... More of this article »
Truist Financial Lowers Marinus Pharmaceuticals (NASDAQ:MRNS) Price Target to $10.00
Marinus Pharmaceuticals (NASDAQ:MRNS – Get Free Report) had its price objective cut by equities researchers at Truist Financial from $25.00 to $10.00 in a research report issued on Wednesday, Benzinga reports. The firm currently... More of this article »
J.B. Hunt Transport Services (NASDAQ:JBHT) PT Lowered to $204.00
J.B. Hunt Transport Services (NASDAQ:JBHT – Get Free Report) had its target price decreased by JPMorgan Chase & Co. from $209.00 to $204.00 in a report issued on Wednesday, Benzinga reports. The firm presently has an “overweight”... More of this article »
JPMorgan Chase & Co. Lowers Darling Ingredients (NYSE:DAR) Price Target to $62.00
Darling Ingredients (NYSE:DAR – Get Free Report) had its price target reduced by stock analysts at JPMorgan Chase & Co. from $66.00 to $62.00 in a note issued to investors on Wednesday, Benzinga reports. The firm currently... More of this article »